|
For more information please contact:
Investment Banking
Greg Giebel
Managing Director
(949) 720-5701
ggiebel@roth.com
Russ Nudelman
Director
(310) 445-5872
rnudelman@roth.com
Equity Capital Markets
Aaron Gurewitz
Head of Equity
Capital Markets
(949) 720-5703
agurewitz@roth.com
Nazan Akdeniz
Senior Vice President
(949) 720-5740
nakdeniz@roth.com
Lou Ellis
Senior Vice President
(949) 720-5739
lellis@roth.com |
Transaction Information
Vivos Therapeutics, Inc. (VVOS), a medical technology company that offers novel and proprietary alternatives for treating mild-to-moderate obstructive sleep apnea, has closed its initial public offering of 4,025,000 shares of its common stock, which includes an additional 525,000 shares pursuant to the full exercise of the over-allotment option granted to the underwriters. The shares were sold at the public offering price of $6.00 per share, resulting in the gross proceeds for Vivos Therapeutics of approximately $24.2 million.
The shares of common stock began trading on the Nasdaq Capital Market under the ticker symbol "VVOS" on Friday, December 11, 2020.
Roth Capital Partners acted as the sole book-running manager for the offering.
About Vivos Therapeutics, Inc.
Vivos Therapeutics Inc. is a medical technology company focused on the development and commercialization of a highly differentiated technology offering a clinically effective non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). We believe our products and technology represent a significant improvement in the treatment of mild-to-moderate OSA versus other treatments such as continuous positive airway pressure (or CPAP). For more information, please visit
https://vivoslife.com.
(Source: Company Press Release | 12.10.20)
About Roth Capital Partners
Roth Capital Partners, LLC (ROTH), is a relationship-driven investment bank focused on serving emerging growth companies and
their investors. As a full-service investment bank, ROTH provides capital raising, M&A advisory, analytical research, trading,
market-making services and corporate access. Headquartered in Newport Beach, CA, ROTH is privately-held and employee owned, and
maintains offices throughout the U.S. For more information on ROTH, please visit
www.roth.com. |
|
Date of Announcement: 02.10.21
The material, information and facts discussed in this announcement other than the information regarding Roth Capital Partners, LLC
("Roth") and its affiliates, are from sources believed to be reliable, but are in no way guaranteed to be complete or accurate. This announcement should not be used as a complete analysis of any
companies, securities or topics discussed herein. Additional information is available upon request. This is not, however, an offer or solicitation of the securities discussed. Any opinions or
estimates in this announcement are subject to change without notice. An investment in any security based on this announcement may involve risks and uncertainties that could cause actual results to differ
materially from the forward-looking statements. Additionally, such investments may involve a high degree of risk and may not be suitable for all investors. No part of this announcement may be
reproduced in any form without the express written permission of Roth. Copyright 2021. |
